Eliminating the complete response penalty from myeloma response assessment

Blood

Volumn 111, Issue 6, 2008, Pages 3297-3298

  Lonial, Sagar ^a   Gertz, Morie A ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; M PROTEIN; MELPHALAN; PREDNISONE;

CANCER COMBINATION CHEMOTHERAPY; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG MEGADOSE; GERIATRIC PATIENT; HUMAN; LETTER; MYELOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; REMISSION; TREATMENT RESPONSE; EVALUATION; MULTIPLE MYELOMA; PATHOLOGY;

EVALUATION STUDIES AS TOPIC; HUMANS; MULTIPLE MYELOMA;

EID: 42449130117     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-01-132456     Document Type: Letter

References (0)